We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Gone for 41 days. Could come back at any time — we're watching for you.
Out of stock 41 days
The 2025-2030 World Outlook for Deep Brain Stimulation Devices for Parkinson's Diseases
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
No price data yet
Price history will appear here once data is collected from Amazon.
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
No price data available for histogram
Description
This study covers the world outlook for deep brain stimulation devices for Parkinson's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of deep brain stimulation devices for Parkinson's diseases as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, Aleva Neurotherapeutics, Beijing PINS Medical, Boston Scientific, Medtronic, PLC, and SceneRay. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).
Product Specifications
- Format
- paperback
- ASIN
- B0CZ2K72XB
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 03 March 2024
- Listed Since
- 29 April 2024
Similar Products You Might Like
99% match
The 2027-2032 World Outlook for Deep Brain Stimulation Devices for Parkinson's Diseases
£890.00
19 Sep 2026
99% match
The 2026-2031 World Outlook for Deep Brain Stimulation Devices for Parkinson's Diseases
£885.00
19 Sep 2026
99% match
The 2026-2031 World Outlook for Parkinson's Disease Deep Brain Stimulation Devices
£885.00
19 Sep 2026
97% match
A Clinical Guide to Parkinson's Disease
Price unavailable
96% match
The 2026-2031 World Outlook for Deep Brain Stimulation Devices
£885.00
23 Sep 2026
96% match
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
£325.00
29 Sep 2026
96% match
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Latin America
£325.00
02 Oct 2026
96% match
Diagnosis and Treatment of Parkinson's Disease
Price unavailable
96% match
Etiology and Pathophysiology of Parkinson's Disease
IntechOpen
£158.35
03 Oct 2026
96% match
Mechanisms in Parkinson's Disease: Models and Treatments
IntechOpen
£158.35
02 Oct 2026
96% match
Parkinson’s Disease in India: From Clinic to Bench
CRC Press
£156.95
11 Sep 2026
96% match
Non-motor Disorders in Parkinson Disease: Basic Science and Advances in Treatment
£52.78
23 Sep 2026
96% match
Clinical Insights: Parkinson's Disease: Medical and Surgical Treatment
£91.00
03 Oct 2026
96% match
Translational Models of Parkinson’s Disease and related Movement Disorders
Elsevier
£135.99
24 Sep 2026
96% match
Parkinson's Disease - Understanding Pathophysiology and Developing Therapeutic Strategies
IntechOpen
£118.98
25 Sep 2026
96% match
Device-Aided Therapies in Parkinson's disease (Volume 7) (International Review of Movement Disorders, Volume 7)
Elsevier
£152.29
03 Oct 2026
96% match
Inclusive Design of a Smart Device for People with Parkinson’s Disease: 4 (Design For Inclusion, 4)
Springer
£77.89
20 Sep 2026
96% match
The 2027-2032 World Outlook for Deep Brain Stimulation Devices
£890.00
19 Sep 2026
96% match
Diagnosis and Treatment of Parkinson's Disease
IntechOpen
£119.00
17 Sep 2026
96% match
Parkinsonism Assessment Techniques - Diagnosis & Rehabilitation Guide
Springer
£120.94
22 Sep 2026
96% match
Clinical Trials In Parkinson's Disease: 160 (Neuromethods, 160)
Humana
£108.75
03 Oct 2026
96% match
Parkinson’s Disease: A Concise Book for Clinicians and Researchers (Neurology - Laboratory and Clinical Research Developments Series)
Nova Medicine and Health
Price unavailable